Dr VG Somani DCGI releases IPA guidelines on Market Complaints. Medical Dialogues Bureau2 March 2020 5:00 AM GMTThe guidelines were released at the recently concluded India Pharmaceutical Forum
NPPA fixes retail price of 44 combo drugs including Metformin, Vildagliptin, Paracetamol; Details Farhat Nasim20 Dec 2019 6:25 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Cadila Healthcare Moraiya plant gets USFDA warning letter for significant violations of CGMP Medical Dialogues Bureau16 Nov 2019 5:41 AM GMTCadila Healthcare failed to clean, maintain, and, as appropriate for the nature of the drug, sanitize and/or sterilise equipment and utensils at...
New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble Medical Dialogues Bureau7 Nov 2019 10:50 AM GMTCadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
Cadila Healthcare gets EIR from USFDA for Baddi facility Medical Dialogues Bureau1 Nov 2019 8:41 AM GMTNew Delhi: Drug firm Cadila Healthcare on Thursday said its Baddi facility in Himachal Pradesh has received establishment inspection report (EIR) from...
Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia Medical Dialogues Bureau25 Oct 2019 6:02 AM GMTHaloperidol is used in the treatment of schizophrenia and for the control of tics and vocal utterances of Tourette syndrome, Cadila Healthcare...
Cadila Healthcare largest API manufacturing site clears USFDA inspection Medical Dialogues Bureau12 Oct 2019 6:11 AM GMTThe US Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredients (API) manufacturing facility at Dabhasa from...
Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol Medical Dialogues Bureau10 Oct 2019 6:04 AM GMTZydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Colesevelam Hydrochloride tablets,...
Cadila Healthcare to sell right of cholesterol-lowering drug Zypitamag for Rs 49 crore Farhat Nasim1 Oct 2019 8:43 AM GMTThe company has entered into an asset purchase agreement to sell its right, title and interest in Zypitamag, along with applicable registrations and...
Cadila Pharma bags ObserveNow Future of Workplace Award among 50 others in fray Medical Dialogues Bureau16 Sep 2019 3:55 AM GMT"The selection was made on the basis of the technologies used in the company, HR policies, and initiatives taken to make the organization an...
Cadila Healthcare Ankleshwar facility successfully completes USFDA inspection Medical Dialogues Bureau1 Aug 2019 3:55 AM GMT"The United States Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredient manufacturing facility located at...
Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila Medical Dialogues Bureau18 July 2019 3:47 AM GMT"Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
